Particle-induced
osteolysis is a major cause of aseptic loosening after
total joint replacement. Earlier studies demonstrated apoptotic macrophages, giant cells, fibroblasts and T-lymphocytes in capsules and interface membranes of patients with aseptic hip implant loosening. The aim of the current study was to determine in a murine calvarial model of wear particle-induced
osteolysis whether inhibition of apoptosis using the pan-
caspase inhibitor
BOC-D-FMK reduces aseptic loosening. Healthy 12-week-old male C57BL/6J mice were treated with
UHMWPE particles and received a daily peritoneal injection of BOK-D-FMK, respectively only
buffer at a dose of 3 mg/kg of
body weight for 12 days until sacrifice.
Bone resorption was measured by histomorphometry, micro CT (computed tomography) and TRAP-5b serum analysis. Apoptosis was measured using
caspase-3 cleaved staining. The results demonstrated that
UHMWPE particles induced stronger apoptotic reactions in macrophages and osteoblasts and increased
bone resorption in non-specifically treated mice, whereas peritoneal application of
BOC-D-FMK significantly counteracted these adverse particle-related effects. We think that in particle-induced
osteolysis apoptosis is pathologically increased, and that failure to reduce the quantity of apoptotic bodies leads to an up-regulation of proinflammatory
cytokines, which may be responsible for the induction of
osteolysis. We showed for the first time in vivo that a reduction in apoptosis leads to a significant reduction in particle-induced
osteolysis. Clinically, the apoptotic cascade could become an interesting novel therapeutic target to modulate particle-induced
osteolysis.